India’s U.S. trade framework faces a new tariff test
A final U.S. 10% tariff action has changed India’s trade position while negotiators work toward a broader agreement that remains unfinished.
A final U.S. 10% tariff action has changed India’s trade position while negotiators work toward a broader agreement that remains unfinished.
Tariffs on some imported patented drugs begin July 31, but generic medicines and biosimilars remain excluded as companies face different rates and deadlines.
World Economy Trade Energy and Technology Scan – USTR opened a Section 301 probe into Germany’s drug pricing, a step that could escalate into tariff pressure.